Target intelligence / Profile preview

Myelin Fragment-Specific Antigen

Molecular classification
Peptide, Antigen
01

Overview

Myelin fragment-specific antigens are peptide fragments derived from myelin proteins that act as antigens, triggering immune responses. These fragments are central in the study of autoimmune demyelinating diseases such as multiple sclerosis (MS), where the immune system targets components of myelin in the central nervous system (CNS). Key myelin antigens include Myelin Oligodendrocyte Glycoprotein (MOG) and Proteolipid Protein 1 (PLP1). Specific peptide fragments from these proteins, such as MOG35–55, are commonly used to induce experimental autoimmune encephalomyelitis (EAE), a model for MS. The immunodominant epitopes often reside on exposed loops or domains accessible at the surface of intact myelin sheaths. Autoimmune responses against specific myelin protein fragments lead to inflammation, demyelination, and neurodegeneration.

Other names
MOG35-55Myelin Oligodendrocyte Glycoprotein fragmentProteolipid Protein 1 fragment
02

Biological functions

Antigen presentationImmune responseT cell activationB cell activation
03

Disease associations

Multiple sclerosisAutoimmune demyelinating diseaseExperimental autoimmune encephalomyelitis (EAE)
04

Safety considerations

Induction of autoimmune responsesPotential for off-target effects in immunotherapy
05

Biomarkers

Anti-MOG antibodiesAnti-PLP1 antibodies

Beyond the preview

Go deeper on Myelin Fragment-Specific Antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myelin Fragment-Specific Antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call